UMEW 最新10-Q变化
将 UMEW 最新的定期申报(10-K/10-Q)与上一份同类型申报逐章节对比:每个章节新增/删除的段落数与原文摘录。全部为确定性文本对比——无相似度评分、无方向判断、非投资建议。
对比:10-Q · 2026-05-14 与上一份 10-Q · 2026-02-24
| 章节 | 结果 | 新增 | 删除 | 微调 | 未变 |
|---|---|---|---|---|---|
| 管理层讨论与分析 | 文字有新增/删除 | +25 | −10 | ~6 | 13 |
| 控制与程序 | 文字有新增/删除 | 0 | 0 | ~2 | 1 |
| 法律诉讼 | 无段落级文字变化 | 0 | 0 | 0 | 1 |
| 风险因素 | 文字有新增/删除 | 0 | 0 | ~1 | 3 |
计数单位为段落;"新增/删除"指相对上一份文件新增/删除的文字,不含方向或好坏判断。
未列出(无法可靠提取或缺失):市场风险(第3项)、其他信息
代表性摘录
每个章节最多 5 条、每条约 300 字符的原文摘录,直接来自两份 SEC 文件。
管理层讨论与分析
相对上期新增的文字 · 来源:10-Q · 2026-05-14
Revenue for the three months ended March 31, 2026 was $351,187, compared to $411 for the three months ended March 31, 2025. The increase was primarily attributable to sales generated through the Company’s PRC subsidiary, reflecting continued distributor channel activity following the Company’s initi…
Revenue from the United States, including sales through the Amazon marketplace platform, was nominal during the current quarter and did not represent a significant portion of total revenue.
The prior-year quarter reflected minimal operating activity, as the Company had not yet commenced meaningful revenue-generating operations in its Asia-Pacific segment.
Cost of revenues for the three months ended March 31, 2026 was $336,035, compared to $2,135 for the three months ended March 31, 2025. The increase was primarily attributable to higher sales volume in the current quarter, driven by distributor channel activity in China, along with associated product…
The Company operates a capital-light production model utilizing third-party manufacturers, co-packers, and specialized ingredient suppliers. The Company sources its diacylglycerol (“DAG”) oil from a strategic manufacturing partner in China. Due to the specialized nature of DAG oil production, suppli…
相对上期删除的文字 · 来源:10-Q · 2026-02-24
Revenue for the three months ended December 31, 2025 was $147,455, compared to $195 for the three months ended December 31, 2024. The increase was primarily attributable to fulfillment of an initial distributor purchase order in China in December 2025 through the Company’s PRC subsidiary, which repr…
Cost of revenues for the three months ended December 31, 2025 was $142,913, compared to $2,583 for the three months ended December 31, 2024. The increase was primarily attributable to higher sales volume in the current quarter, including fulfillment of a distributor order in China and increased Amaz…
Gross profit for the three months ended December 31, 2025 was $4,542, compared to a gross loss of $2,388 in the prior-year quarter. Gross margin for the current quarter remained low primarily due to product mix, distributor pricing on an initial bulk order, fulfillment and logistics costs, and the i…
Selling, general and administrative expenses were $143,296 for the three months ended December 31, 2025, compared to $12,322 for the three months ended December 31, 2024. The increase was primarily attributable to higher professional and advisory fees, increased executive compensation, and expanded …
During the quarter, the Company engaged an external advisory firm for corporate and strategic advisory services and recorded a one-time fee of approximately $32,500. The Company also incurred consulting expenses under a services agreement with a business advisor at approximately $2,500 per month. In…
如何读 10-Q 的风险因素(第 1A 项)
10-Q 的风险因素章节有三种常见形态,本页按其一分类展示:
- 指向(pointer) — 公司仅声明"无重大变化"并指向年度 10-K 的完整风险因素;本季没有自己的风险文本可对比。
- 部分更新(partial) — 公司写明"除下述外无重大变化",只更新部分风险;摘录展示的正是本季新增的内容。
- 全文重述(restated) — 本季重新给出完整风险因素。若上一季只是"指向",则无法逐段对比,本页会将其标为"本季全文重述"。
这只是对文件结构的客观描述,不构成对风险高低的判断。
数据来自 SEC EDGAR 两份申报文件的文本级对比 · 确定性计算(无 AI 生成内容)· 仅供参考 · 非投资建议